JAMA Surg:不确定肺结节癌变的可能性分析!

2018-03-28 xing.T MedSci原创

由此可见,临床医生很少提供高风险IPN患者癌症概率的定量记录,即使是从广泛的癌症概率范围内抽取的患者。目前临床实践中对癌症风险的定性描述不确切,而且变化很大。应该使用与IPN预测的癌症风险相关的标准量表来与患者和其他临床医生进行交流。

临床指南建议临床医师估计大于8mm的不确定肺结节(IPN)患者发展为恶性肿瘤的可能性。这些指南的依从性仍未知的。最近,该研究旨在明确临床医师是否记录高危IPN患者恶性肿瘤的可能性,并将这些定性或定量预测与经过验证的Mayo临床模型进行比较。

从2003年1月1日至2015年12月31日期间,研究人员对来自三级医疗退伍军人事务部医院的数据进行了一项单一中心、回顾性队列研究。队列1包含291位在2003年1月1日至2015年12月31日期间接受手术切除已知或疑似肺癌的退伍军人。队列2包含了在2003年1月1日至2012年12月31日期间随机抽取的接受住院或门诊IPNs肺部评估的239名退伍军人。该研究的暴露指标为临床医师记录恶性肿瘤的定量或定性概率。研究人员对来自于肺脏和/或胸外科临床医师的文献以及多学科肿瘤委员会介绍的信息进行审查,并使用描述性统计方法对定量或定性恶性肿瘤预测的任何记录进行提取和总结。研究人员将临床医生的预测与Mayo诊所模型的风险估计进行了比较。

队列1包含的291名患者,282名(96.9%)为男性;平均(SD)年龄为64.6(9.0)岁。队列2中的239名患者,233名(97.5%)为男性;平均(SD)年龄为65.5(10.8)岁。在队列1中,291例患者中有258例(88.7%)参与者患有癌症,258例患者中有110例(48.9%)确诊为癌症。队列1中只有13例患者(4.5%)队列2中只有3例患者在组织诊断之前有记录的恶性肿瘤定量预测。其余患者,队列1内278例中的217例(78.1%)患者和队列2内236例中的149例(63.1%)患者具有癌症风险的定性表述。在队列2中,79例患者中23例(29.1%)患者没有任何记录的恶性肿瘤风险声明,最终被诊断为癌症。定性风险声明分布在32个大类中。最常用的表述与梅奥诊所模型预测队列1与队列2的比较相一致。梅奥诊所模型预测的癌症概率中位数为68.7%(范围为2.4%-100.0%)。定性风险声明大致与梅奥预测一致。

由此可见,临床医生很少提供高风险IPN患者癌症概率的定量记录,即使是从广泛的癌症概率范围内抽取的患者。目前临床实践中对癌症风险的定性描述不确切,而且变化很大。应该使用与IPN预测的癌症风险相关的标准量表来与患者和其他临床医生进行交流。

原始出处:

Amelia W. Maiga,et al.Communication About the Probability of Cancer in Indeterminate Pulmonary Nodules.JAMA Surg.2017.https://jamanetwork.com/journals/jamasurgery/article-abstract/2665416?redirect=true

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=303852, encodeId=6b95303852c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Sun Apr 08 09:55:30 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302484, encodeId=ff2630248443, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Wed Apr 04 00:02:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557067, encodeId=b4de155e067b2, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Fri Mar 30 10:46:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300750, encodeId=c6d3300e504b, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Mar 29 07:01:54 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-04-08 1222becem95暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=303852, encodeId=6b95303852c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Sun Apr 08 09:55:30 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302484, encodeId=ff2630248443, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Wed Apr 04 00:02:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557067, encodeId=b4de155e067b2, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Fri Mar 30 10:46:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300750, encodeId=c6d3300e504b, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Mar 29 07:01:54 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-04-04 1222becem95暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=303852, encodeId=6b95303852c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Sun Apr 08 09:55:30 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302484, encodeId=ff2630248443, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Wed Apr 04 00:02:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557067, encodeId=b4de155e067b2, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Fri Mar 30 10:46:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300750, encodeId=c6d3300e504b, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Mar 29 07:01:54 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-03-30 axin014
  4. [GetPortalCommentsPageByObjectIdResponse(id=303852, encodeId=6b95303852c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Sun Apr 08 09:55:30 CST 2018, time=2018-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302484, encodeId=ff2630248443, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40ad2312069, createdName=1222becem95暂无昵称, createdTime=Wed Apr 04 00:02:33 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557067, encodeId=b4de155e067b2, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Fri Mar 30 10:46:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300750, encodeId=c6d3300e504b, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Mar 29 07:01:54 CST 2018, time=2018-03-29, status=1, ipAttribution=)]
    2018-03-29 owlhealth

    不错耶.学习了

    0